These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 3473688)
1. Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemia. Hoelzer D; Thiel E; Löffler H; Büchner T; Ganser A; Heil G; Kurrle E; Heimpel H; Koch P; Lipp T Semin Oncol; 1987 Jun; 14(2 Suppl 1):92-7. PubMed ID: 3473688 [No Abstract] [Full Text] [Related]
2. Teniposide (VM-26) and ara-C in the treatment of adult acute lymphoblastic leukemia. Linker CA; Levitt LJ; O'Donnell M; Ries CA; Forman SJ Semin Oncol; 1987 Jun; 14(2 Suppl 1):78-85. PubMed ID: 3473686 [No Abstract] [Full Text] [Related]
3. [VM-26 and cytosine arabinoside in the treatment of acute refractory lymphoblastic leukemia in adults]. Marín P; Grañena A; Carreras E; Sierra J; Olivé MT; Rozman C Sangre (Barc); 1984; 29(4-A):399-404. PubMed ID: 6594782 [No Abstract] [Full Text] [Related]
4. The epipodophyllotoxin teniposide in therapy for childhood acute lymphocytic leukemia. Rivera GK J Clin Oncol; 1988 Feb; 6(2):191-3. PubMed ID: 3276820 [No Abstract] [Full Text] [Related]
5. Teniposide in the treatment of leukemia: a case study of conflicting priorities in the development of drugs for fatal diseases. Grem JL; Hoth DF; Leyland-Jones B; King SA; Ungerleider RS; Wittes RE J Clin Oncol; 1988 Feb; 6(2):351-79. PubMed ID: 3276827 [TBL] [Abstract][Full Text] [Related]
6. Teniposide and cytarabine combination chemotherapy in the treatment of relapsed adolescent and adult acute lymphoblastic leukemia. Sanz GF; Sanz MA; Rafecas FJ; Martínez JA; Martín-Aragonés G; Marty ML Cancer Treat Rep; 1986 Nov; 70(11):1321-3. PubMed ID: 3464352 [TBL] [Abstract][Full Text] [Related]
11. VM-26 and cytarabine combination chemotherapy in refractory or relapsed adult acute lymphoblastic leukemia. Carella AM; Santini G; Martinengo M; Giordano D; Nati S; Congiu A; Risso M; Vimercati R; Cerri R; Rossi E Haematologica; 1984; 69(6):747-51. PubMed ID: 6441752 [No Abstract] [Full Text] [Related]
12. [Treatment of acute refractory lymphoblastic leukemia in the adult with VM-26 and ARA-C]. Rafecas FJ; Sanz MA Sangre (Barc); 1984; 29(6):1052-3. PubMed ID: 6598235 [No Abstract] [Full Text] [Related]
13. Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group. Tower RL; Jones TL; Camitta BM; Asselin BL; Bell BA; Chauvenet A; Devidas M; Halperin EC; Pullen J; Shuster JJ; Winick N; Kurtzberg J J Pediatr Hematol Oncol; 2014 Jul; 36(5):353-61. PubMed ID: 24608079 [TBL] [Abstract][Full Text] [Related]
14. Teniposide plus cytarabine improves outcome in childhood acute lymphoblastic leukemia presenting with a leukocyte count greater than or equal to 100 x 10(9)/L. Dahl GV; Rivera GK; Look AT; Hustu HO; Kalwinsky DK; Abromowitch M; Mirro J; Ochs J; Murphy SB; Dodge RK J Clin Oncol; 1987 Jul; 5(7):1015-21. PubMed ID: 3474355 [TBL] [Abstract][Full Text] [Related]
15. [Acute lymphoblastic leukemia of high risk: results of a therapeutic protocol]. Castel V; Verdeguer A; Ferris J; Esquembre C An Esp Pediatr; 1987 Nov; 27(5):331-4. PubMed ID: 3481522 [TBL] [Abstract][Full Text] [Related]
16. Severe hypertensive reactions to teniposide (VM-26) in infants with congenital leukemia. Shimizu H; Frankel LS; Culbert SJ Am J Pediatr Hematol Oncol; 1987; 9(3):239-41. PubMed ID: 3479027 [TBL] [Abstract][Full Text] [Related]
17. [Induction of remission by sequential treatment with cytosine arabinoside (araC/high dose) and L-asparaginase]. Martín-Aragonés G; Sanz MA; Martínez JA; Rafecas FJ; Gomis F; Lorenzo I; Sanz G; Marty ML Sangre (Barc); 1985; 30(1):15-21. PubMed ID: 3859023 [No Abstract] [Full Text] [Related]
18. Teniposide is not effective in chronic lymphocytic leukemia. Zagonel V; Tirelli U; Veronesi A; Galligioni E; Tumolo S; Roncadin M; Carbone A; Grigoletto E Blut; 1986 Jan; 52(1):59-61. PubMed ID: 3632912 [TBL] [Abstract][Full Text] [Related]
19. Intermediate and high-dose cytosine arabinoside-containing regimens for induction and consolidation therapy for patients with acute lymphoblastic leukemia and lymphoblastic non-Hodgkin's lymphoma: the Leyden experience and review of the literature. Peters WG; Willemze R; Colly LP Semin Oncol; 1987 Jun; 14(2 Suppl 1):86-91. PubMed ID: 3473687 [No Abstract] [Full Text] [Related]
20. [Results of a clinical study of an epipodophyllotoxin preparation (VM 26) in children with hemoblastoses]. Kondrat'eva NA; Makhonova LA; Maiakova SA; Vialushkin BIa Probl Gematol Pereliv Krovi; 1981 Apr; 26(4):12-6. PubMed ID: 7015318 [No Abstract] [Full Text] [Related] [Next] [New Search]